Toray Q1 FY2027: Operating Profit Jumps 72%, First-Half Guidance Raised

Toray's consolidated Q1 FY2027 (April–June 2026) results: revenue was ¥679.0 billion, up 14.0% year on year; business profit ¥48.4 billion (+66.6%); operating profit ¥47.3 billion (+72.1%); and net profit attributable to owners of the parent ¥31.3 billion (+82.3%). The global economy faced uncertainty from energy and raw material price surges driven by Middle East conflicts, but AI and semiconductor investments provided support, along with a moderate U.S. expansion and resilient domestic consumption. Under its new medium-term management initiative 'IGNITION 2028' launched in FY2026, Toray advanced growth strategies and structural reforms centered on ROIC, achieving revenue and profit growth across all segments. Carbon fiber composites and performance chemicals were standout contributors. The effects of emergency price hikes and cost improvements offset raw material inflation, leading to higher margins.

All four business segments posted higher revenue and profit, with total business profit reaching ¥48.4 billion.

The Fibers & Textiles segment faced fierce competition in apparel but captured demand; industrial applications saw a gradual recovery in automotive, and price hikes plus cost improvements lifted profit. Performance Chemicals saw steady sales and successful price pass-through in resins and chemicals despite raw material costs; films benefited from strong demand for MLCC electronic components and optical uses, as well as materials for power inductors, though OLED-related materials were hit by sluggish Chinese panel demand. Carbon Fiber Composite Materials delivered a sharp expansion: aerospace and space applications surged, and sports and general industrial uses recovered, driving revenue up 34.1% and business profit up 71.3%. Water Treatment & Healthcare saw firm sales of reverse osmosis membranes for Middle East projects and the Americas, partially offset by weak China; in pharmaceuticals and medical, drug sales were sluggish but value-added dialyzers and cost reductions boosted profit.

Total assets as of June 30, 2026 stood at ¥3,492.1 billion, up ¥15.1 billion from the previous fiscal year-end, as yen depreciation inflated overseas subsidiaries' translated values and inventories rose. Liabilities fell ¥5.0 billion to ¥1,544.2 billion, while equity increased ¥20.1 billion to ¥1,947.9 billion, lifting the equity attributable to owners of the parent ratio to 52.0%. Cash flow from operations was ¥54.1 billion, investing outflows of ¥33.1 billion resulted in free cash flow of ¥21.0 billion. Financing activities used ¥25.0 billion for debt repayments and dividends, leaving a cash balance of ¥263.9 billion. The annual dividend forecast for FY2027 was raised by ¥6 to ¥26 per share, with an interim dividend of ¥13 (including a ¥3 commemorative dividend). No share buybacks were conducted, but the company emphasizes capital efficiency under its ROIC-driven policy.

Key risks identified:

• Geopolitical risk: soaring crude oil and raw material prices and supply constraints from Middle East conflicts, with potential economic downturn if prolonged.
• China economic slowdown: stagnant domestic demand and declining panel demand affecting performance chemicals and water treatment.
• Foreign exchange: a stronger yen beyond the assumed rate of ¥155/$ would erode overseas earnings.
• U.S. trade policy: uncertainty could disrupt supply chains and demand.

The company aims to build resilience through structural reforms and thorough price pass-through.

Toray revised upward its cumulative first-half (April–September) forecast, reflecting strong Q1 results. All key metrics were raised from previous guidance. Full-year forecasts were left unchanged (revenue ¥2,830 billion, business profit ¥160 billion, net profit ¥90 billion), with a review planned at the time of the second-quarter announcement, based on the external environment. The exchange rate assumption of ¥155 per dollar is maintained.

Toray launched its medium-term management initiative 'IGNITION 2028' this fiscal year, built on three pillars: enhancing economic value, enhancing social value, and strengthening the management base, with ROIC at the center. Early results are visible in profit margin improvement.

In May, Toray agreed to sell all shares in its performance chemicals subsidiary Soda Aromatic to the Japanese subsidiary of Korea's Samyang Corporation; the transaction closed on July 1, 2026. This will generate a one-time gain of about ¥8.0 billion (after tax) in the interim consolidated period, improving the financial base and optimizing the business portfolio.

Additionally, the company restructured its reporting segments, merging the former Environment & Engineering and Life Science businesses into Water Treatment & Healthcare, aiming for resource concentration and synergy.